Our goal is to develop medicines for significant unmet medical needs by acquiring promising drug compounds, designing studies via crowdsourced methods, and conducting those clinical studies with unmatched productivity. TLS addresses a key barrier to innovation in biotech and pharma today caused by high clinical trials costs. We aim to license or sell compounds we have developed to mid-large pharma.